EUVIMEDEUVIMED entdecken
Leitlinie

The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025

Glenn F Pierce, Margareth C Ozelo, Johnny Mahlangu iD, Amy L Dunn, Marlene Beijlevelt, Rose Bender iD, Manuel Carcao iD, Donna Coffin iD, Enrico Ferri Grazzi, Graham R Foster, Julie Frantsve-Hawley, Alfonso Iorio iD und 12 weitere

Haemophilia · 2026-01 · 32 (1) · 20-54

DOI: 10.1111/hae.70113 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Haemophilia, online erschienen am 25.10.2025. Verfasst von Glenn F Pierce und 23 weiteren Autor:innen. Beteiligte Einrichtung: World Federation of Hemophilia, Montréal, Québec, Canada. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 127 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AAV gene therapybleeding disordershaemophiliamanagement guidelinesmonitoringoutcomesshared decision‐making

Autor:innen und Institutionen

  • World Federation of Hemophilia, Montréal, Québec, Canada.
  • Hemocentro UNICAMP, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
  • Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa and Clinical Haematology Unit, Charlotte Maxeke Johannesburg…
  • Division of Hematology/Oncology and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio, USA and The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Yale University School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Johnny Mahlangu, Rose Bender, Manuel Carcao, Donna Coffin, Alfonso Iorio, Gwendolyn E Kaeser, Barbara A Konkle, Magdalena Lewandowska, Wolfgang Miesbach, Brian O'Mahony, Steven Pipe, Ulrike M Reiss

Zitieren

APA

Pierce, G. F., Ozelo, M. C., Mahlangu, J., Dunn, A. L., Beijlevelt, M., Bender, R., Carcao, M., Coffin, D., Grazzi, E. F., Foster, G. R., Frantsve-Hawley, J., Iorio, A., Jackson, S., Kaczmarek, R., Kaeser, G. E., Konkle, B. A., Lewandowska, M., Miesbach, W., O'Mahony, B., …, & WFH AAV Gene Therapy Guidelines Expert Panel (2026). The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025. Haemophilia, 32(1), 20-54. https://doi.org/10.1111/hae.70113

Vancouver

Pierce GF, Ozelo MC, Mahlangu J, Dunn AL, Beijlevelt M, Bender R, et al. The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025. Haemophilia. 2026;32(1):20-54. doi:10.1111/hae.70113

BibTeX
@article{Pierce2026,
  author = {Pierce, Glenn F and Ozelo, Margareth C and Mahlangu, Johnny and Dunn, Amy L and Beijlevelt, Marlene and Bender, Rose and Carcao, Manuel and Coffin, Donna and Grazzi, Enrico Ferri and Foster, Graham R and Frantsve-Hawley, Julie and Iorio, Alfonso and Jackson, Shannon and Kaczmarek, Radoslaw and Kaeser, Gwendolyn E and Konkle, Barbara A and Lewandowska, Magdalena and Miesbach, Wolfgang and O'Mahony, Brian and Pipe, Steven and Reiss, Ulrike M and Wilson, Amy K and Gouider, Emna and WFH AAV Gene Therapy Guidelines Expert Panel, WFH AAV Gene Therapy Guidelines Expert Panel},
  title = {The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025},
  journal = {Haemophilia},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {20--54},
  doi = {10.1111/hae.70113}
}
Kostenlos starten →